March 2020 Clinical Watch Newsletter

April 29, 2020

In this issue of Clinical Watch, we highlight aspects of Medicaid programs that are affected COVID-19 and suggest prior authorization criteria for a new lipid-lowering drug. Lastly, we review claims data for psychotropic polypharmacy in children.

For more information about a specific topic, please contact Janelle Sheen or Karen Powell. Be sure to stay tuned for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Article
Leadership in Times of Crisis
Leadership in Times of Crisis

Next Article
Pandemic EBT – What It Is and How We Help
Pandemic EBT – What It Is and How We Help